Examined relationship between obstructive sleep apnea (OSA) and endothelial function (EF) in 267 patients with an apnoea-hypopnoea index (AHI) of 15-50/hr, and known cardio/cerebro-vascular disease (CVD), or CVD risk factors. OSA severity indices (oxygen desaturation index (ODI), AHI and percentage of sleep time below 90% oxygen saturation (total sleep time <90) and EF (EndoPAT F-RHI), were assessed.
Compared endothelial progenitor cells (EPCs), numbers and functions in 40 male acute myocardial infarction (AMI) patients with sleep disordered breathing, (AMI-SDB, n=19), and 21 matched patients without SDB-(AMI-only), to determine the effects of intermittent hypoxia (IH) in-vitro on EPCs proliferative and angiogenic properties. SDB status was determined using WatchPAT. Effects of IH in-vitro were studied in twelve healthy subjects.
RESULTS:
Circulating EPCs, vascular endothelial growth factor (VEGF) in monocytes, EC-CFUs numbers, and EC-CFUs paracrine effects on endothelial tube formation were significantly higher in AMI-SDB patients, while plasma stromal cell-derived factor (SDF)-1 levels were significantly lower. EC-CFUs numbers and their paracrine effects on endothelial tube formation were increased after exposure to IH in-vitro, compared to normoxia. Investigated the potential contribution of the intrinsic stress-induced mitochondrial pathway in extending neutrophil survival under intermittent hypoxia (IH) conditions, using neutrophils of healthy individuals under in-vitro IH and those of OSA patients (SH) in-vivo, based on the balance between pro-apoptotic Bax and anti-apoptotic Mcl-1 protein expression, and the potential involvement of p38MAPK and ERK1/2 signaling pathways in the control of Mcl-1 expression. Sleep disordered breathing was quantified by either WatchPAT or PSG.
CONCLUSION:

RESULTS:
Compared to normoxia, IH and SH up-regulated Mcl-1 by about 2-fold, and down-regulated Bax by 41% and 27%, respectively. IH induced ERK1/2 and p38MAPKs phosphorylation, whereas SH induced only p38MAPK. In both IH, and OSA neutrophils, Bax/Mcl-1 ratios were lower lower than normoxic controls (p=0.015), and Bax did not co-localize with mitochondria. Assessed whether OSA is associated with endothelial dysfunction (EndoPAT RHI), and if this association is influenced by gender, in 479 subjects drawn from a large population-based cohort of 30,000 subjects aged 30-65 years.
CONCLUSION:
RESULTS:
OSA was diagnosed in 55.5% (n = 266) of subjects. The RHI was significantly lower in subjects with severe OSA than in those without OSA (p = 0.002). In the multivariate model for RHI, a significant interaction between OSA and gender was found. In gender-specific multivariate linear regression models, adjusting for conventional cardiovascular risk factors, OSA was an independent predictor of a low RHI in women (p = 0.006) but not in men. The association between OSA and low RHI in women was independent of postmenopausal status.
CONCLUSION:
In a large population-based sample of middle-aged subjects, OSA was independently associated with impaired digital vascular function in women only.
http://www.ncbi.nlm.nih.gov/pubmed/23471187
Habitual flavonoid intake and endothelial function in healthy humans. Examined the relationship between endothelial function (EF), and dietary flavonoids in 19 healthy adults (mean age 72 years). Flavonoid intake was assessed via a focused food frequency questionnaire. EF was determined by EndoPAT RHI, both before and after a dose of flavonoidrich cocoa.
RESULTS:
Background flavonoid intake and baseline RHI were significantly positively correlated (r = 0.7, p = 0.001), and the RHI response to cocoa was also significantly correlated with simultaneous blood flavanol concentration, (r = 0.5, p = 0.03). Describes the SAS CARE 1 study on the effects of sleep-disordered breathing (SDB), on clinical evolution, vascular functions, and markers within the first three-months after an acute cerebrovascular event (CE), and the SAS CARE 2 study to assess the effect of continuous positive airways pressure (CPAP), on clinical evolution, cardiovascular events, and mortality as well as vascular functions and markers at 12 and 24 months after acute CE, in 200 acute CE patients. Vascular functions and markers (blood pressure, heart rate variability, endothelial function (EndoPAT RHI) and specific humoral factors will be assessed in the acute phase and at three-months follow-up. SAS CARE 2 will include a sample of patients with acute CE in the previous 60-90 days, receiving CPAP as appropriate.
CONCLUSION: Individual variation in EF in
CONCLUSION:
These studies will improve our understanding of the role of clinical SCB in patients with acute cerebrovascular event and the feasibility/efficacy of CPAP in selected patients with SDB. An Invited Review, overviewing the status of ambulatory devices in the diagnosis and management of Obstructive Sleep Apnea (OSA). Authors describe the increasing interest in the use of simplified, ambulatory models of care involving clinical prediction tools, portable sleep monitoring and home auto-titrating continuous positive airway pressure (CPAP), in view of the ever mounting, and increasingly unmet pressure on laboratory-based sleep services. Authors summarized six randomised controlled studies evaluating the clinical effectiveness of ambulatory management strategies versus traditional laboratory-based care for patients with OSA. Amongst these is the Watch PAT based study by Berry et al (Sleep 2008; 31: 1423-31) , regarding which the reviewers surmised that compared to full split night lab PSG and CPAP titration, Watch-PAT 100 diagnosis followed by autotitrating CPAP for pressure determination, showed no significant differences in CPAP compliance, change in Epworth Sleepiness Scale, change in functional outcomes of sleep questionnaire, patient satisfaction with CPAP or mean residual AHI on CPAP, between the two groups.
